Ultrasound Surgical Devices Market

Reduced Recovery Period Garners Attention for Ultrasound Surgical Devices Market

The Dental Anesthesia Market is valued at USD 2.3 Bn in 2026 and is projected to reach USD 3.8 Bn, growing at a CAGR of 5% by 2033.The global ultrasound surgical devices market is projected to reach US$5.80 Bn by 2027 from US$4.0 Bn in 2021, expanding at a CAGR of 5.8% during the forecast period. Rise in ageing population which translates to higher number of surgeries has created a fertile ground for market growth. A shift towards minimally invasive surgeries has also led to an unprecedented support for ultrasound surgical devices.

Ultrasound surgical devices offer better visibility with high resolution images, allowing precision on scalpel operation for complex incisions. Through years of improvements, there has been minimal blood loss and lesser stiches, thus shortening the recovery period. It has also been observed that ultrasound surgical devices have been pivotal in reduces the chances of post-operative infections and complications.

Uterine treatment especially ultrasound ablation for uterine fibroids has been the key application area for ultrasound surgical devices. Furthermore, sports injuries have also benefitted greatly from precision and accuracy of these devices, giving the global ultrasound surgical devices market a shot in the arm.

Tremendous Innovation in Surgical Instruments Drives Global Ultrasound Surgical Devices Market

Continuous innovation and launch of new products have been generating healthy competition in the global ultrasound surgical devices market as major players strive to introduce new products to stay relevant. In for instance, in September 2021, Medtronic launched an ultrasonic device, Sonicision, a cordless, ultrasound dissection device. This is designed to provide surgeons free movement while conducting surgeries in the operation theatres. The reusable generator easily fits in the palm of the surgeon, thereby providing ease of use while conducting surgeries.

In 2021, Bioventus one of the leading players in this field received FDA approval for its product named BoneScalpel® Access™. This device is powered by neXus Ultrasonic Surgical Aspirator System, a next generation ultrasound surgical system built on a proprietary digital algorithm to provide additional power, control, and maneuverability. This system provides the advantage of tissue removal of both the types i.e. tissue and bone. The BoneScalpel Access hand piece provides surgeons with a new option for confined spaces during minimally invasive surgery, enabling safe and powerful bone removal with maximum visualization.

In May 2021, Olympus announced launch of its new product name BF-UC190F, an ultrasound bronchoscope. This is the latest addition to its robust portfolio of endobronchial ultrasound devices for minimally invasive lung cancer diagnosis and staging via needle biopsy.

High Intensity Focused Ultrasound (HIFU) to Prompt Market Growth

Ultrasound has the ability to penetrate into deeper tissue and provide enhanced images of the targeted tissue through its small wavelengths and also provide accurate dimensions of the tumor or fibroid. Earlier, ultrasound was used for treatment of ablation of tissue using high intensity ultrasound waves with evolution and continuous technological advances HIFU was introduced. This treatment provides higher resolution ultrasound images and then HIFU high energy is delivered on the affected tissue or tumor leading to dissection of the tumor without affecting the normal vasculature. The tumor is destroyed by tissue coagulative thermal energy. The HIFU therapy finds its application in the treatment of facial skin tightening, melanoma, renal and prostate cancer.

Presently there are two therapy systems available in the market Sonablate®500 and Ablatherm which useful for dermal treatments. Other commercially available systems include ExAblate 2000 (Insightec), JM2.5C, Chongqing Haifu Technology Co., Ltd., Chongqing, China), HIFUNIT 9000 (Shanghai Aishen Technology, Shanghai, China). There is also a custom made mobile HIFU unit from (Storz Medical AG, Kreuzlingen, Switzerland). Factors such as lower dose of anesthesia, outdoor procedure, less blood loss and quicker recovery has boosted the uptake of HIFU which would consequently prompt the market growth for HIFU ablators.

North America Lead Global Ultrasound Surgical Devices Market as High Demand for Minimally Invasive Surgeries

North America accounted to grab the largest market share owing to growing demand for minimally invasive surgeries and favorable reimbursements for these procedures. In addition, the rise in the aging population along with the growing incidence of cancer has triggered the market growth for ultrasound surgical procedures. Moreover, less risk and no blood loss post-operatively has boosted the market growth for ultrasound surgical procedures in the treatment of uterine fibroids and tumors. Asia Pacific region is expected to bag the highest growth rate during the forecast period owing to growing awareness of less invasive procedures and a rise in disposable income for treatments. Commercially, growing demands for such procedures have compelled the big players in this market to explore lucrative opportunities in this region.

Global Ultrasound Surgical Devices Market: Key Players

• Septodont Holding
• Dentsply Sirona
• 3M Company
• Zimmer Biomet
• Envista Holdings Corporation
• Carestream Dental
• Patterson Companies, Inc.
• Danaher Corporation
• Kulzer GmbH
• VOCO GmbH
• Ultradent Products, Inc.
• Aspen Dental Management
• Hu-Friedy Mfg. Co., LLC
• Procter & Gamble (Oral Care segment)
• Pierre Rolland Group

Global Ultrasound Surgical Devices Market is Segmented as Below:

Product Outlook

• Generators
• Consumables

Type Outlook

• High-intensity Focused Ultrasonic (HIFU) Ablators
• Magnetic Resonance-guided Focused Ultrasonic (MRGFUS) Ablators
• Ultrasonic Surgical Ablation Systems
• Shock Wave Therapy Systems

Application Outlook

• Cardiology
• Gynaecology
• General Surgery
• Urology
• Bariatric Surgery
• Others

End Users

• Hospitals
• Ambulatory Surgical Centres
• Others

Regional Outlook

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa